NDC 71332-001 – Tavalisse
Fostamatinib 100 mg/1 · Tablet · Oral
Product NDC71332-001
Product details
- Brand name
- Tavalisse
- Generic name
- Fostamatinib
- Labeler
- Rigel Pharmaceuticals, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA209299
- Marketed since
- May 9, 2018
- Listing expires
- December 31, 2026
Active ingredients
- Fostamatinib 100 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 71332-001-01 | 60 TABLET in 1 BOTTLE (71332-001-01) | May 9, 2018 |
Other Tavalisse products
- 71332-002 Fostamatinib 150 mg/1 · Tablet · Rigel Pharmaceuticals, Inc.